---
title: "The solid-state battery concept is active again, POWER HF has 9 limit-ups in 12 days"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/231143441.md"
description: "POWER HF has achieved 9 consecutive trading limits in 12 days, Enpack has hit the daily limit, DONGWEI TECHNOLOGY has risen over 10%, and YINGHE TECHNOLOGY, Guangdong Jiayuan Technology, LMGF, and Lingpai Technology have also followed suit"
datetime: "2025-03-10T01:48:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/231143441.md)
  - [en](https://longbridge.com/en/news/231143441.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/231143441.md)
generator: "portal-rs"
---

# The solid-state battery concept is active again, POWER HF has 9 limit-ups in 12 days

POWER HF has achieved 9 consecutive 涨停 in 12 days, Enpack has hit the 涨停， DONGWEI TECHNOLOGY has risen over 10%, and YINGHE TECHNOLOGY, Guangdong Jiayuan Technology, LMGF, and Lingpai Technology have also followed suit

### Related Stocks

- [300457.CN](https://longbridge.com/en/quote/300457.CN.md)
- [605100.CN](https://longbridge.com/en/quote/605100.CN.md)
- [688388.CN](https://longbridge.com/en/quote/688388.CN.md)
- [002734.CN](https://longbridge.com/en/quote/002734.CN.md)
- [002846.CN](https://longbridge.com/en/quote/002846.CN.md)
- [688700.CN](https://longbridge.com/en/quote/688700.CN.md)
- [300530.CN](https://longbridge.com/en/quote/300530.CN.md)

## Related News & Research

- [Xinhua Pharma unit Xincat’s azithromycin tablets pass China generic consistency evaluation](https://longbridge.com/en/news/297485179.md)
- [Why You Might Be Interested In Alivus Life Sciences Limited (NSE:ALIVUS) For Its Upcoming Dividend](https://longbridge.com/en/news/297244607.md)
- [REG - AIM - AIM Notice - 28/08/2026](https://longbridge.com/en/news/297278146.md)
- [Kalbe Farma schedules annual public expose](https://longbridge.com/en/news/297296656.md)
- [COSCO SHIPPING: Revenue up 2.6%, net profit down 23.6%, interim dividend RMB0.43 per share](https://longbridge.com/en/news/297342819.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**